NCT05989529View on ClinicalTrials.gov

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Borderline Personality Disorder
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences | Biotech Hunter | Biotech Hunter